These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23150076)

  • 41. Characterization of microsomal prostaglandin E synthase 1 inhibitors.
    Korotkova M; Jakobsson PJ
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):64-9. PubMed ID: 24138533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of the disposition of a novel p38 MAPK inhibitor, AKP-001, and its metabolites in rats with a simple physiologically based pharmacokinetic model.
    Shirota K; Kaneko M; Sasaki M; Minato K; Fujikata A; Ohta S; Hisaka A; Suzuki H
    Drug Metab Dispos; 2015 Feb; 43(2):217-26. PubMed ID: 25422274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of Dual 5-Lipoxygenase/Microsomal Prostaglandin E2 Synthase-1 Inhibitory Effect of Natural and Synthetic Acronychia-Type Isoprenylated Acetophenones.
    Svouraki A; Garscha U; Kouloura E; Pace S; Pergola C; Krauth V; Rossi A; Sautebin L; Halabalaki M; Werz O; Gaboriaud-Kolar N; Skaltsounis AL
    J Nat Prod; 2017 Mar; 80(3):699-706. PubMed ID: 28240894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Arzanol, a prenylated heterodimeric phloroglucinyl pyrone, inhibits eicosanoid biosynthesis and exhibits anti-inflammatory efficacy in vivo.
    Bauer J; Koeberle A; Dehm F; Pollastro F; Appendino G; Northoff H; Rossi A; Sautebin L; Werz O
    Biochem Pharmacol; 2011 Jan; 81(2):259-68. PubMed ID: 20933508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonacidic inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1) identified by a multistep virtual screening protocol.
    Rörsch F; Wobst I; Zettl H; Schubert-Zsilavecz M; Grösch S; Geisslinger G; Schneider G; Proschak E
    J Med Chem; 2010 Jan; 53(2):911-5. PubMed ID: 20025212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacodynamic and pharmacokinetic characterisation of RBx 7796: a novel 5-lipoxygenase inhibitor.
    Shirumalla RK; Sharma P; Dastidar SG; Paliwal JK; Kakar S; Varshney B; Singh Saini G; Sattigeri V; Salman M; Ray A
    Inflamm Res; 2008 Mar; 57(3):135-43. PubMed ID: 18369577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation of
    K Pinjari MJS; Somani R; Gilhotra RM
    Indian J Pharmacol; 2017; 49(4):297-303. PubMed ID: 29326490
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dynamic eicosanoid responses upon different inhibitor and combination treatments on the arachidonic acid metabolic network.
    He C; Wu Y; Lai Y; Cai Z; Liu Y; Lai L
    Mol Biosyst; 2012 Apr; 8(5):1585-94. PubMed ID: 22446875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and pharmacological evaluation of a selected library of new potential anti-inflammatory agents bearing the gamma-hydroxybutenolide scaffold: a new class of inhibitors of prostanoid production through the selective modulation of microsomal prostaglandin E synthase-1 expression.
    Guerrero MD; Aquino M; Bruno I; Terencio MC; Paya M; Riccio R; Gomez-Paloma L
    J Med Chem; 2007 May; 50(9):2176-84. PubMed ID: 17407277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-lipoxygenase inhibitors with histamine H(1) receptor antagonist activity.
    Lewis TA; Bayless L; Eckman JB; Ellis JL; Grewal G; Libertine L; Marie Nicolas J; Scannell RT; Wels BF; Wenberg K; Wypij DM
    Bioorg Med Chem Lett; 2004 May; 14(9):2265-8. PubMed ID: 15081022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E₂ synthase-1 enzyme (mPGES-1).
    Lauro G; Strocchia M; Terracciano S; Bruno I; Fischer K; Pergola C; Werz O; Riccio R; Bifulco G
    Eur J Med Chem; 2014 Jun; 80():407-15. PubMed ID: 24794772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diverse ways of perturbing the human arachidonic acid metabolic network to control inflammation.
    Meng H; Liu Y; Lai L
    Acc Chem Res; 2015 Aug; 48(8):2242-50. PubMed ID: 26237215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. P-glycoprotein plays a role in the oral absorption of BMS-387032, a potent cyclin-dependent kinase 2 inhibitor, in rats.
    Kamath AV; Chong S; Chang M; Marathe PH
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):110-6. PubMed ID: 15338193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibacterial galloylated alkylphloroglucinol glucosides from myrtle (Myrtus communis).
    Appendino G; Maxia L; Bettoni P; Locatelli M; Valdivia C; Ballero M; Stavri M; Gibbons S; Sterner O
    J Nat Prod; 2006 Feb; 69(2):251-4. PubMed ID: 16499325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Munronia pinnata (Wall.) Theob.: unveiling phytochemistry and dual inhibition of 5-lipoxygenase and microsomal prostaglandin E2 synthase (mPGES)-1.
    Napagoda M; Gerstmeier J; Koeberle A; Wesely S; Popella S; Lorenz S; Scheubert K; Böcker S; Svatoš A; Werz O
    J Ethnopharmacol; 2014 Feb; 151(2):882-90. PubMed ID: 24315851
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design and synthesis of a second series of triazole-based compounds as potent dual mPGES-1 and 5-lipoxygenase inhibitors.
    Chini MG; De Simone R; Bruno I; Riccio R; Dehm F; Weinigel C; Barz D; Werz O; Bifulco G
    Eur J Med Chem; 2012 Aug; 54():311-23. PubMed ID: 22683242
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PGE synthase inhibitors as an alternative to COX-2 inhibitors.
    Jachak SM
    Curr Opin Investig Drugs; 2007 May; 8(5):411-5. PubMed ID: 17520870
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antinociceptive, anti-inflammatory effects and acute toxicity of aqueous and ethanolic extracts of Myrtus communis L. Aerial parts in mice.
    Hosseinzadeh H; Khoshdel M; Ghorbani M
    J Acupunct Meridian Stud; 2011 Dec; 4(4):242-7. PubMed ID: 22196507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.